private placement

Cycurion postpones shareholder vote on warrant-related stock issuance to March 19 due to insufficient quorum. The vote involves issuing over 3.3M shares from December 2025 private placement.

Thesis Gold raises C$44M from AngloGold Ashanti and Centerra Gold to advance its Lawyers-Ranch gold-silver project in British Columbia.

Brainstorm Cell Therapeutics raised $2M in February through private placement at $0.60/share. Funds support general operations, regulatory work, and Phase 3b trial preparations for ALS therapy NurOwn.

Ideal Power raises $14M through mixed equity financing to accelerate commercialization of its B-TRAN semiconductor technology and expand customer design-ins.

Brainstorm Cell raised $1M via private placement at $0.60/share, above market price. Funds support Phase 3b ALS therapy trials and regulatory efforts.

Thesis Gold secures C$44M from AngloGold Ashanti and Centerra Gold to fund its British Columbia gold-silver project development and exploration activities.

Sensei Biotherapeutics stock surged 230% after acquiring Faeth Therapeutics and securing $200M investment, expanding its oncology pipeline with PIKTOR therapy.

Nasus Pharma raises $15M to advance intranasal epinephrine product toward FDA trials. Funds support NS002 development and pipeline expansion.

Hot Chili raises A$40M to advance its Chilean copper-gold Costa Fuego project, with backing from major investors including Glencore. Funds will support environmental assessments and La Verde integration.